
    
      Design: a prospective, double-blinded, randomized, clinical trial

      Patient and methods:

      Patients with adhesive capsulitis for at least 3 months were enrolled and randomly allocated
      into group 1 (hydrodilatation with low dose steroid ) and group 2 (hydrodilatation with high
      dose steroid). The patients were evaluated before treatment and were reevaluated 0, 6, and 12
      weeks after the beginning of the treatment. Outcomes measures included a pain scale (visual
      analog scale), range of motion, Constant shoulder score, Shoulder Pain And Disability Index
    
  